Production and characterization of HCV particles from serum-free culture (Q39546680)

12 September 2017

Production and characterization of HCV particles from serum-free culture (English)

1 reference

12 September 2017

Daisuke Akazawa

1

1 reference

12 September 2017

Kenichi Morikawa

2

1 reference

12 September 2017

Noriaki Omi

3

1 reference

12 September 2017

Hitoshi Takahashi

4

1 reference

12 September 2017

Noriko Nakamura

5

1 reference

12 September 2017

Hidenori Mochizuki

6

1 reference

12 September 2017

Tomoko Date

7

1 reference

12 September 2017

Koji Ishii

8

1 reference

12 September 2017

Tetsuro Suzuki

9

1 reference

12 September 2017

Takaji Wakita

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

7 May 2011

1 reference

12 September 2017

1 reference

12 September 2017

29

1 reference

12 September 2017

29-30

1 reference

12 September 2017

4821-4828

1 reference

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Characterization of hepatitis C RNA-containing particles from human liver by density and size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Association of hepatitis C virus envelope proteins with exosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

The NS3 Helicase and NS5B-to-3'X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Cell culture and infection system for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Real-time detection system for quantification of hepatitis C virus genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Association of hepatitis C virus in human sera with beta-lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.04.069

10.1016/J.VACCINE.2011.04.069

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference